KemPharm, Inc. Receives Patent From the USPTO for Novel Pain Drug Candidate, KP201
6/11/2013 1:04:01 PM
More...
|
KemPharm, Inc.'s KP201 Featured at the International Conference on Opioids
6/4/2013 7:34:06 AM
More...
|
KemPharm, Inc. Advances KP201 Clinical and Commercial Program With Completion of Tablet Registration Activities
4/17/2013 9:06:32 AM
More...
|
KemPharm, Inc. Receives Notice of Allowance for Novel Pain Drug Candidate, KP201
4/3/2013 11:49:49 AM
More...
|
KemPharm, Inc. Supports Recent FDA Recommendations for Hydrocodone-Containing Compounds and Abuse-Deterrent Opioids
2/14/2013 9:50:31 AM
More...
|
KemPharm, Inc. Receives USAN Approval for Nonproprietary Name of Novel Pain Drug Candidate, KP201
1/7/2013 11:23:36 AM
More...
|
KemPharm, Inc. to Present at Biotech Showcase 2013
1/3/2013 7:16:16 AM
More...
|
KemPharm, Inc. Receives Positive Feedback From FDA on KP201 Clinical Plan
11/20/2012 9:12:01 AM
More...
|
KemPharm, Inc. Presents Key Findings for Novel Hydromorphone Prodrug at 2012 International Conference on Opioids
6/11/2012 9:24:58 AM
More...
|
KemPharm, Inc. Focuses on Advanced Pain Management Franchise
5/22/2012 9:55:50 AM
More...
|
|